The landscape of modern healthcare is undergoing a fundamental shift from reactive treatment to proactive longevity. In alignment with this evolution, 3xP Global is proud to announce the investment in nuAura Health through our Health Innovation Fund. This partnership underscores 3xP Global's commitment to backing transformative technologies that redefine the boundaries of medical care and wellness.
nuAura Health is a preventive, precision health platform built to close the gap between reactive care and proactive health management. Today, most people engage with healthcare only once symptoms appear – often when metabolic, cardiovascular, hormonal, or inflammatory imbalances are already well established. By integrating advanced diagnostics, expert-led interpretation, lifestyle tracking, and personalized health planning into one seamless digital experience, nuAura shifts the focus earlier – enabling informed decisions, continuous insight, and structured long-term health optimization.
The company’s methodology is rooted in the "4P" medicine framework: Personalized, Predictive, Preventive, and Participatory. While the concept of high-touch, concierge-grade preventive medicine has historically been reserved for those able to pay thousands of dollars in annual fees, nuAura utilizes a technology-enabled format to deliver this level of care at a subscription scale. This democratization of precision health transforms fragmented data into integrated insight, moving the patient experience away from one-off consultations and toward a continuous, data-driven partnership.
"A partnership with 3xP Global marks an important milestone for nuAura. It reinforces the scale and ambition of what we’re building: a structured, preventive health delivered intelligently and accessibly. This investment strengthens our ability to reshape how proactive healthcare is experienced across Europe," says Ash Black, CEO of nuAura Health.
For 3xP Global, the decision to support nuAura Health stems from a shared belief that the future of medicine lies in the intersection of human expertise and scalable technology. By providing a seamless experience that prioritizes prevention over treatment, nuAura is well-positioned to reduce the global burden of chronic disease while empowering individuals to take agency over their own biological data.
"Our investment in nuAura reflects our conviction that precision health should be the standard, not the exception. By bridging the gap between sophisticated diagnostics and everyday lifestyle management, nuAura is building the infrastructure for a more resilient society. We are thrilled to support Ash and the entire team as they scale this essential vision," highlights Raul Saraiva, Health & Life Sciences Investments at 3xP Global.
As nuAura Health continues to expand its reach across Europe, 3xP Global remains dedicated to fostering an ecosystem where innovation leads to tangible improvements in human health and longevity.
This investment round was led by 3xP Global Health Innovation Fund, under the Consolidar Programme within the Capitalisation and Resilience Fund, managed by Banco Português de Fomento.
